Kayentis
PrivateLast Round
Debt
Mar 28, 2023
Total Funding Raised
$22.15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Kayentis is a healthtech company that provides electronic Clinical Outcome Assessment (eCOA) and Decentralized Clinical Trial (DCT) solutions for the collection of clinical trial data from patients and sites.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Vertical SaaS, Biotechnology
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kayentis Comparables
Compare Kayentis with similar companies based on industry and business-model similarity.
Kayentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 28, 2023 | ||||
| Growth Equity | Mar 28, 2023 | ||||
| Growth Equity | Dec 2, 2020 | ||||
| Growth Equity | Oct 10, 2016 | ||||
| VC Round | Feb 1, 2015 | ||||
Series C | Sep 1, 2007 |
Key People
Founding team and executive leadership
Kayentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Capital | Growth Equity |
| Extens | Growth Equity, VC Round |
| LBO France | Growth Equity |
| Bpifrance | Growth Equity |
| Seventure Partners | Series C, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 62% MoM.
- Jan 1, 2025
Opened new office in Tokyo, adding to Grenoble and Boston locations.
Kayentis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kayentis's valuation, stock price, and market status.